Jivi 1000 Unit

JIVI 1000 Unit is a recombinant antihemophilic factor used for hemophilia B treatment. This intravenous powder for solution helps manage bleeding episodes and prevent surgical bleeding.

JIVI 1000 Unit is primarily used to control and prevent bleeding in patients with hemophilia B, a condition characterized by a deficiency in clotting factor IX. It is administered intravenously to replace the missing clotting factor, aiding in blood coagulation. This medication is often used during surgical procedures to minimize blood loss and can be part of a routine prophylaxis regimen to prevent bleeding episodes.

Common effects of JIVI 1000 Unit may include localized reactions at the injection site, such as redness or swelling. Some users might experience mild flu-like symptoms, including headache or fatigue. These effects are generally temporary and resolve on their own. Severe reactions are rare but should be reported to a healthcare provider immediately.

JIVI 1000 Unit should be handled with care, ensuring proper storage and preparation. It is essential to follow the prescribed administration guidelines to minimize the risk of adverse reactions. Patients with known allergies to any components of the medication should avoid its use. Always consult a healthcare provider before starting or adjusting any treatment regimen.

JIVI 1000 Unit may interact with other medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods might also influence the effectiveness of this medication, so it is advisable to discuss dietary and lifestyle factors with a healthcare professional.